Personalized T-cell Therapy Improves Immune Response Against Cancer
Investigators have developed a novel personalized T-cell therapy approach that may identify specific targets unique to a patient’s cancer cells more effectively than current treatments, according to findings published in Nature.
Watterson Elected to National Academy of Inventors
Daniel Martin Watterson, PhD, the John G. Searle Professor of Molecular Biology and Biochemistry, has been named a 2022 fellow of the National Academy of Inventors.
Study Identifies New Therapeutic Target for Tumor Treatment
Northwestern Medicine scientists have identified a new therapeutic target against tumor cells and developed a compound which slows tumor growth and bolsters immune response.